Literature DB >> 15466277

A genome scan for ESRD in black families enriched for nondiabetic nephropathy.

Barry I Freedman1, Carl D Langefeld, Stephen S Rich, Christopher J Valis, Michèle M Sale, Adrienne H Williams, W Mark Brown, Stephanie R Beck, Pamela J Hicks, Donald W Bowden.   

Abstract

Nephropathy is a complex disorder, with predisposition influenced by the interplay of both genetic and environmental factors. As part of an effort to map genes that predispose to ESRD, a genome scan was performed in 264 black pedigrees that contained 296 ESRD-affected sibling pairs using multipoint nonparametric linkage analysis methods. The cause of ESRD in index cases was consistent with hypertension-associated ESRD. Nonparametric linkage (NPL) regression provided modest evidence of linkage to 9p21.3 near D9S1121 (logarithm of odds [LOD] = 2.03), 1q25.1 near D1S1589 (LOD = 1.62), and 13q33.3 near D13S796 (LOD = 1.02). Adjusting for the evidence of linkage at the other loci through the NPL regression analysis provided evidence for linkage to 1q25.1, 6p23, and 9p21.3. The NPL regression and ordered subset analyses suggest that the evidence for linkage significantly increased with early onset of ESRD (2q32.1 LOD = 3.89, 13q13.1 LOD = 3.90), increased BMI (8p22 LOD = 3.37, 13q33.3 LOD = 5.20, 18p11.3 LOD = 2.38), early onset of hypertension (14q21.1 LOD = 3.19, 20q13.2 LOD = 2.32), and late onset of hypertension (4q13.1 LOD = 3.44, 5p15.33 LOD = 2.82). Multipoint single-locus linkage analysis provided modest evidence of linkage to nondiabetic ESRD on 9p21.3, 1q25.1 (in the region of the podocin gene), and 13q33.3. NPL regression and ordered subset analyses also identified loci on 13q13.1 and 13q33.3 as contributing to early-onset ESRD and ESRD in the presence of increased BMI, respectively. These regions should receive priority in the search for loci that contribute susceptibility to nondiabetic nephropathy.

Entities:  

Mesh:

Year:  2004        PMID: 15466277     DOI: 10.1097/01.ASN.0000141312.39483.4F

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  20 in total

1.  Candidate genes for non-diabetic ESRD in African Americans: a genome-wide association study using pooled DNA.

Authors:  Meredith A Bostrom; Lingyi Lu; Jeff Chou; Pamela J Hicks; Jianzhao Xu; Carl D Langefeld; Donald W Bowden; Barry I Freedman
Journal:  Hum Genet       Date:  2010-06-08       Impact factor: 4.132

2.  Genetic association and gene-gene interaction analyses in African American dialysis patients with nondiabetic nephropathy.

Authors:  Meredith A Bostrom; W H Linda Kao; Man Li; Hanna E Abboud; Sharon G Adler; Sudha K Iyengar; Paul L Kimmel; Robert L Hanson; Susanne B Nicholas; Rebekah S Rasooly; John R Sedor; Josef Coresh; Orly F Kohn; David J Leehey; Denyse Thornley-Brown; Erwin P Bottinger; Michael S Lipkowitz; Lucy A Meoni; Michael J Klag; Lingyi Lu; Pamela J Hicks; Carl D Langefeld; Rulan S Parekh; Donald W Bowden; Barry I Freedman
Journal:  Am J Kidney Dis       Date:  2011-11-25       Impact factor: 8.860

3.  Translating associations between common kidney diseases and genetic variation into the clinic.

Authors:  Paul E Drawz; John R Sedor
Journal:  Semin Nephrol       Date:  2010-03       Impact factor: 5.299

4.  SNP in the genome-wide association study hotspot on chromosome 9p21 confers susceptibility to diabetic nephropathy in type 1 diabetes.

Authors:  E Fagerholm; E Ahlqvist; C Forsblom; N Sandholm; A Syreeni; M Parkkonen; A J McKnight; L Tarnow; A P Maxwell; H-H Parving; L Groop; P-H Groop
Journal:  Diabetologia       Date:  2012-05-29       Impact factor: 10.122

5.  MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis.

Authors:  Jeffrey B Kopp; Michael W Smith; George W Nelson; Randall C Johnson; Barry I Freedman; Donald W Bowden; Taras Oleksyk; Louise M McKenzie; Hiroshi Kajiyama; Tejinder S Ahuja; Jeffrey S Berns; William Briggs; Monique E Cho; Richard A Dart; Paul L Kimmel; Stephen M Korbet; Donna M Michel; Michele H Mokrzycki; Jeffrey R Schelling; Eric Simon; Howard Trachtman; David Vlahov; Cheryl A Winkler
Journal:  Nat Genet       Date:  2008-09-14       Impact factor: 38.330

Review 6.  Insights to the genetics of diabetic nephropathy through a genome-wide association study of the GoKinD collection.

Authors:  Marcus G Pezzolesi; Jan Skupien; Josyf C Mychaleckyj; James H Warram; Andrzej S Krolewski
Journal:  Semin Nephrol       Date:  2010-03       Impact factor: 5.299

7.  The 9p21 coronary artery disease locus and kidney dysfunction in patients with Type 2 diabetes mellitus.

Authors:  Salvatore De Cosmo; Sabrina Prudente; Olga Lamacchia; Daniela Lucchesi; Hetal Shah; Christine Mendonca; Laura Pucci; Luana Mercuri; Ernest V Gervino; Thomas H Hauser; Diego Bailetti; Giuseppe Penno; Mauro Cignarelli; Alessandro Doria; Vincenzo Trischitta
Journal:  Nephrol Dial Transplant       Date:  2012-05-23       Impact factor: 5.992

8.  Association analysis of the ephrin-B2 gene in African-Americans with end-stage renal disease.

Authors:  Pamela J Hicks; Jennifer L Staten; Nicholette D Palmer; Carl D Langefeld; Julie T Ziegler; Keith L Keene; Michele M Sale; Donald W Bowden; Barry I Freedman
Journal:  Am J Nephrol       Date:  2008-06-26       Impact factor: 3.754

9.  Heritability of the severity of diabetic retinopathy: the FIND-Eye study.

Authors:  Nedal H Arar; Barry I Freedman; Sharon G Adler; Sudha K Iyengar; Emily Y Chew; Mathew D Davis; Scott G Satko; Donald W Bowden; Ravi Duggirala; Robert C Elston; Xiuxing Guo; Robert L Hanson; Robert P Igo; Eli Ipp; Paul L Kimmel; William C Knowler; Julio Molineros; Robert G Nelson; Madeleine V Pahl; Shannon R E Quade; Rebekah S Rasooly; Jerome I Rotter; Mohammed F Saad; Marina Scavini; Jeffrey R Schelling; John R Sedor; Vallabh O Shah; Philip G Zager; Hanna E Abboud
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-09       Impact factor: 4.799

10.  Relevance of the ACTN4 gene in African-Americans with non-diabetic end-stage renal disease.

Authors:  Meredith A Bostrom; Peter Perlegas; Lingyi Lu; Pamela J Hicks; Greg Hawkins; Maggie C Y Ng; Carl D Langefeld; Barry I Freedman; Donald W Bowden
Journal:  Am J Nephrol       Date:  2012-09-04       Impact factor: 3.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.